Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Addiction

Study finds impulsivity and psychological distress predict problematic ecstasy use

by Eric W. Dolan
July 2, 2020
in Addiction, Psychopharmacology
(Photo credit: DEA)

(Photo credit: DEA)

Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

Individuals experiencing higher levels of psychological distress and those who are more impulsive may be at a greater risk of problematic ecstasy use, according to new research published in Addictive Behaviors. The research found that both of these factors are related to an increased tendency to use ecstasy to cope.

“Only a small proportion of people who use ecstasy develop any associated problems, such as difficulties controlling their use of the drug. I wanted to investigate what might predispose people to these problems,” said study author Sally Meikle, a PhD student at the University of Melbourne.

“I had found this was an under-researched topic. Most research in the area has looked at the predictors of frequent use or consumption of large amounts of ecstasy, which doesn’t necessarily translate into problem use.”

The researchers surveyed 483 individuals from 34 different countries who had used ecstasy on at least one occasion. Approximately 10% of the sample scored above the cut-off for possible “dependence” based on a self-report questionnaire. These participants indicated that they thought their ecstasy use was out of control, worried about their use of ecstasy, and wished they could stop.

The researchers also found this type of problematic ecstasy use was associated with three psychological factors.

“This study found some evidence to suggest that ecstasy users who are experiencing psychological distress, and those who are more impulsive, might be at a greater risk of developing problems associated with their use of the drug. Further, the link between psychological distress and ecstasy use problems might be explained by individuals using ecstasy to cope with their distress, which is something that has also been found with other drugs in prior research,”

“What we can take away from these results is that attempts to curb ecstasy use problems should acknowledge the diversity of users and their motives for use.”

The researchers controlled for variables such as age, education, and overall level of ecstasy use. But like all research, the study includes some limitations.

“This research is an initial step towards understanding why some ecstasy users develop problems. We used an online survey to collect cross sectional data from ecstasy users, but longitudinal data is needed to be sure of the cause-and-effect relationships here.”

The study, “Individual differences in distress, impulsivity, and motives for use as predictors of problematic ecstasy use“, was authored by Sally Meikle, Olivia Carter, and Gillinder Bedi.

TweetSendScanShareSendPin3ShareShareShareShareShare

RELATED

Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Depression

New research links antidepressant effects of escitalopram to endocannabinoid system changes

May 12, 2025

In a rodent model of childhood adversity, escitalopram treatment during adolescence reduced signs of emotional distress. The study also found gene-level changes in the endocannabinoid system, pointing to a possible biological mechanism for the drug’s effectiveness.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails
CBD enhances verbal episodic memory — potentially counteracting the memory impairments associated with THC
Cannabis

Cannabidiol boosts social learning by enhancing brain acetylcholine signaling, study finds

May 11, 2025

Cannabidiol appears to improve social memory in mice, according to new research in Psychopharmacology. The study shows that CBD enhances the ability to remember food-related information from peers by increasing acetylcholine activity in the basal forebrain.

Read moreDetails
A pill bottle with pills inside
Depression

Common antidepressant may increase pain sensitivity later in life if taken during adolescence

May 11, 2025

A new animal study shows that adolescent use of fluoxetine, a commonly prescribed antidepressant, may have long-lasting effects on how the brain processes pain. Female mice exposed to the drug displayed increased sensitivity to heat stimuli as adults.

Read moreDetails
Psilocybin use has surged in the United States since 2019
Psilocybin

Psilocybin use has surged in the United States since 2019

May 10, 2025

Psilocybin use has surged across the U.S. in recent years, with the biggest increases seen among adults with depression, anxiety, and chronic pain.

Read moreDetails
Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025

Researchers investigating the psychedelic drug DOPR discovered that very low doses can enhance motivation in low-performing mice—without triggering behaviors linked to hallucinations. The findings point to the therapeutic potential of psychedelics at doses too low to alter perception.

Read moreDetails
Researchers uncover causal evidence that cannabis legalization reduces problematic consumption
Cannabis

Researchers uncover causal evidence that cannabis legalization reduces problematic consumption

May 8, 2025

Researchers in Switzerland have completed the first randomized trial comparing legal and illegal cannabis use. The study suggests that public health-oriented cannabis access may help reduce misuse, particularly among people with more complex patterns of drug use.

Read moreDetails
A dose of psilocybin stirred the brain of a barely conscious woman
Neuroimaging

A dose of psilocybin stirred the brain of a barely conscious woman

May 7, 2025

In a groundbreaking case report, scientists administered psilocybin to a woman in a minimally conscious state and observed increased brain complexity and new spontaneous behavior—offering a glimpse into how psychedelics might influence consciousness in severe brain injury patients.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Can you train your brain to unsee optical illusions? Scientists think so

New research links antidepressant effects of escitalopram to endocannabinoid system changes

College students still follow familiar relationship paths despite dating app era, study finds

Women who misrepresent themselves on dating apps more likely to consider cosmetic surgery

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

Abnormal brain rhythms may offer new insight into Alzheimer’s disease and its link to epilepsy

Left-wing authoritarians are less likely to support physically strong men as leaders

Genetic mutations predict Alzheimer’s onset like a ticking clock, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy